Cidara Therapeutics (NASDAQ:CDTX – Get Free Report) and Mesoblast (NASDAQ:MESO – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, institutional ownership, dividends, risk, analyst recommendations, earnings and valuation. Institutional & Insider Ownership 35.8% of Cidara Therapeutics […]